KRAS and non-small cell lung carcinoma: In our previous study, we reported that tricin is the main bioactive compound in Rhizoma phragmitis and that it exhibited selective cytotoxic effects on KRAS-mutant NSCLC cell lines such as H358, H2122 and LLC cells (Li J.-X.